Can methotrexate cause lung damage over time?
Yes. Methotrexate can cause lung injury, sometimes developing gradually with long-term use. The best-known form is methotrexate-induced pneumonitis, an inflammatory reaction in the lungs that can occur at any time during treatment, including after months of therapy. Symptoms often develop over weeks to months rather than suddenly.
What lung problems does methotrexate cause?
The lung side effects most often discussed with methotrexate include:
- Methotrexate pneumonitis (inflammation of lung tissue), which may present with cough and shortness of breath.
- Lung toxicity that can mimic infection or other lung diseases, so clinicians often need to rule out causes like pneumonia before attributing symptoms to methotrexate.
What symptoms should people watch for?
Patients are commonly advised to seek medical care promptly if they develop new or worsening:
- Dry cough
- Shortness of breath, especially with exertion
- Fever or feeling acutely ill (which can overlap with infection)
Because these symptoms can come from other causes, evaluation is important rather than stopping the drug without medical guidance.
Who is more at risk of methotrexate lung toxicity?
Risk can increase in people with factors that affect the lungs or raise the chance of overlapping lung problems. Clinicians often take extra care in patients with:
- Pre-existing lung disease
- Prior radiation to the chest
- Significant past or current lung infections or other interstitial lung conditions
- Higher-dose or long-term exposure to methotrexate (risk varies by individual)
How is methotrexate lung injury diagnosed and treated?
Diagnosis usually involves combining symptom history with tests that may include chest imaging and sometimes lung function testing, plus ruling out infections. Treatment commonly focuses on stopping methotrexate and using anti-inflammatory therapy (often corticosteroids) when methotrexate pneumonitis is suspected, under specialist care.
Can the damage be permanent?
It can be. Some people recover fully, but others may have persistent lung impairment depending on how severe the injury is and how quickly treatment is started after symptoms appear.
Is there a way to reduce the risk?
Clinicians reduce risk by:
- Monitoring patients on methotrexate for respiratory symptoms
- Using appropriate dosing and follow-up
- Being cautious when patients have other lung risk factors
- Investigating cough or breathing changes promptly instead of attributing them to “just getting older” or mild illness
If you want, tell me your dose, how long you’ve been on methotrexate, and what symptoms (if any) you’re having, and I can help you think through what to ask your clinician and what conditions typically need to be ruled out.